AMELA PETTY: Open Payments
NPI 1922344043 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 107 payments from 12 companies in 2025. Trend: 2023 $2,935 · 2024 $2,416 · 2025 $2,312
Food & beverage: $2,312
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 40 | $886 |
| PROTEGA PHARMACEUTIALS INC | 27 | $467 |
| Collegium Pharmaceutical, Inc. | 12 | $240 |
| Averitas Pharma Inc. | 5 | $205 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $118 |
| PFIZER INC. | 5 | $93 |
| SPR Therapeutics, Inc | 2 | $81 |
| SI-BONE, INC. | 2 | $54 |
| ABBVIE INC. | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
Products named: PROCLAIM, ROXYBOND, ETERNA, QUTENZA, Belbuca, RELISTOR, NURTEC ODT, SPRINT PNS System.
Industry payments across TX — which companies pay providers there.
